India New Issue-Eris Lifesciences to issue STRPP bonds, bankers say
MUMBAI, June 5 (Reuters) - India's Eris Lifesciences ERIS.NS plans to raise up to 12.5
billion rupees ($149.8 million) through the sale of separately transferable redeemable principal
part (STRPP) bonds maturing in three years, three bankers said on Wednesday.
It will pay a coupon of 8.73% coupon on this bond issue and has invited bids on Thursday,
they said.
Here is the list of deals reported so far on June 5:
Issuer Tenure Coupon (in %) Issue size (in Bidding Rating
bln rupees)* date
Eris 3 years 8.73 12.5 June 6 AA- (India
Lifesciences Ratings)
HDB Financial 3 years and 8.3333 2.75+7.25 June 6 AAA (Crisil,
Services 2 months Careedge)
*Size includes base plus greenshoe for some issues
($1 = 83.4480 Indian rupees)
(Reporting by Bhakti Tambe; Editing by Sonia Cheema)
((Bhakti.Tambe@thomsonreuters.com))
Recent news on Eris Lifesciences
See all newsIndia's Eris Lifesciences gains on strong quarterly results
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit 1.84 Billion Rupees
Brief: Eris Lifesciences Says Krishnakumar Vaidyanathan Resigns As Executive Director & COO
Brief: Eris Lifesciences Ltd Says June-Quarter Consol Net Profit 1.42 Billion Rupees
Brief: Eris Lifesciences March-Quarter Consol Net Profit 2.82 Billion Rupees